EBITDA

For the third consecutive time, Equisoft's AI-native system is named a 'Luminary,' highlighting a major tech shift for insurers in Latin America.

StepStone Real Estate secures top PERE awards for its global firm and a landmark European deal, validating its powerful GP-led secondaries strategy.

NBA legend Kevin Garnett partners with smart mobility brand NAVEE, signaling a major play to conquer the Americas' market beyond the daily commute.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

In a deal highlighting intense focus on supply chain resilience, J.F. Lehman acquires critical forgings provider Forged Solutions Group from Arlington Capital.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

In a strategic move, CCC Intelligent Solutions adds former Salesforce and Informatica exec John Schweitzer to its board, signaling a major push in AI and data.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

Manhattan's top landlord promotes Harrison Sitomer from intern to President, signaling a focus on stability as it navigates a complex office market.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.

A new partnership between Japan's Marubeni and US firm Branford Castle promises to reshape the lower middle-market, offering small businesses global reach.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.